Teachers Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$5.74M Buy
470,987
+382,495
+432% +$4.89M 0.01% 1327
2018
Q4
$1.01M Buy
88,492
+3,862
+5% +$62.3K ﹤0.01% 2183
2018
Q3
$1.84M Sell
84,630
-698
-0.8% -$14.6K ﹤0.01% 2010
2018
Q2
$1.51M Buy
85,328
+7,154
+9% +$145K ﹤0.01% 2122
2018
Q1
$1.65M Sell
78,174
-232
-0.3% -$4.52K ﹤0.01% 1936
2017
Q4
$1.14M Buy
78,406
+15,912
+25% +$246K ﹤0.01% 2178
2017
Q3
$986K Sell
62,494
-121
-0.2% -$1.78K ﹤0.01% 2241
2017
Q2
$778K Buy
62,615
+4,238
+7% +$49.1K ﹤0.01% 2384
2017
Q1
$949K Sell
58,377
-12,571
-18% -$182K ﹤0.01% 2212
2016
Q4
$1.07M Buy
70,948
+443
+0.6% +$6.26K ﹤0.01% 2142
2016
Q3
$1.07M Sell
70,505
-4,025
-5% -$163K ﹤0.01% 2035
2016
Q2
$2.89M Buy
74,530
+14,115
+23% +$507K 0.01% 1435
2016
Q1
$1.68M Buy
60,415
+3,931
+7% +$131K ﹤0.01% 1677
2015
Q4
$3.04M Buy
56,484
+8,450
+18% +$426K 0.01% 1357
2015
Q3
$1.92M Buy
48,034
+12,109
+34% +$395K ﹤0.01% 1604
2015
Q2
$1.15M Buy
35,925
+11,845
+49% +$300K ﹤0.01% 2030
2015
Q1
$575K Hold
24,080
﹤0.01% 2359
2014
Q4
$425K Hold
24,080
﹤0.01% 2517
2014
Q3
$330K Hold
24,080
﹤0.01% 2623
2014
Q2
$406K Buy
+24,080
New +$398K ﹤0.01% 2552

Other funds holding ITCI

Teachers Advisors's ITCI Position: Q1 2019 in Review

Teachers Advisors increased its Intra-Cellular Therapies Inc. (ITCI) stake by 432% in Q1 2019, buying an estimated $4.89M and bringing the position to 470,987 shares worth $5.74M. The position accounts for 0.01% of the portfolio, ranked #1327.

Teachers Advisors first reported a position in ITCI in Q2 2014 and has held it in 20 quarters since. 127 funds tracked by Wall St. Rank hold ITCI as of Q1 2019.

  • Teachers Advisors held 470,987 shares of Intra-Cellular Therapies Inc. worth $5.74M as of Q1 2019.
  • Teachers Advisors bought 382,495 Intra-Cellular Therapies Inc. shares in Q1 2019, an estimated $4.89M.
  • Intra-Cellular Therapies Inc. made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1327 holding.
  • Teachers Advisors first reported a position in Intra-Cellular Therapies Inc. in Q2 2014 and has held it in 20 quarters since.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.